title: Erythropoietin and fibrinolysis effects on platelet activity.
authors.forename: D
authors.initials: D
authors.lastname: Stenver
authors.forename: B
authors.initials: B
authors.lastname: Nielsen
authors.forename: L L
authors.initials: LL
authors.lastname: Jeppesen
authors.forename: J D
authors.initials: JD
authors.lastname: Nielsen
authors.forename: K
authors.initials: K
authors.lastname: Winther
authors.forename: C
authors.initials: C
authors.lastname: Haedersdal
authors.forename: J
authors.initials: J
authors.lastname: Mehlsen
mesh_terms: D001792:Blood Platelets / Q000502:physiology*; D004921:Erythropoietin / Q000009:adverse effects / Q000494:pharmacology*; D005342:Fibrinolysis; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D010974:Platelet Aggregation; D011994:Recombinant Proteins
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin